Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01816035
Title Ado-Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Washington
Indications

Her2-receptor positive breast cancer

Therapies

Ado-trastuzumab emtansine

Age Groups: adult
Covered Countries USA


No variant requirements are available.